COVID-19 Vaccine for Children (COVID-19 Trial)

"There are 42 different locations at which this trial is accepting patients, three of which are MedPharmics in Lafayette, Louisiana, Wee Care Pediatrics - Roy in Roy, Utah, and PanAmerican Clinical Research in Brownsville, Texas."

"That is correct. The information on clinicaltrials.gov does show that the study is still recruiting patients. This trial was originally posted on 7/22/2022 and was most recently edited on 10/14/2022. 3600 patients are needed for this study, which will be conducted at 39 different locations."

"The age bracket that this trial is recruiting from are those who have not yet turned 12, and are at least 6 months old."

"The clinical trial is still actively recruiting patients, as of 10/14/2022. According to the original posting on clinicaltrials.gov from 7/22/2022, 3600 participants are needed for the study which will be taking place at 39 locations."

"The primary outcome of this study will be the incidence and severity of medically attended adverse events (MAAEs) over a period of 730 days. Secondary outcomes include the incidence rate of participants with first episode of diagnostic test-positive moderate or severe COVID-19, the incidence rate of participants with first episode of PCR-positive mild, moderate, or severe COVID-19, and antibodies to SARS-CoV-2 nucleoprotein at specified time points."

"This clinical trial is looking for 3600 participants aged between 6 months and 11 years who currently have covid-19. The following additional criteria must be met: Pediatric participants 6 months to < 12 years of age at randomization, determined to be healthy or medically stable by the investigator (based on review of health status, vital signs [to include body temperature], medical history, and targeted physical examination [to include body weight]). Vital signs must be within normal range prior to the first vaccination, according to the child's age, sex, and height., Participant and parent(s)/caregiver(s) or legally"